The Breakdown

Let’s look at the most directly relevant data point. An acute comparison study where HMB was put against leucine found that leucine outperformed HMB on muscle protein synthesis (no surprise there!). But HMB slowed muscle protein breakdown by 57%¹. That’s not a modest effect at all! 

This is the crux of my argument. HMB is not an anabolic, but rather an amazing anti-catabolic supplement.

When & Where HMB’s Anti-Catabolic Effects Matter

Specificity becomes critical here.
HMB’s value is context-dependent, and understanding that context is the difference between a pseudo-supplement and the one that should have a place in our stack.

Early Training and Eccentric-Heavy Loading

HMB is strongest in one specific side: the first several weeks of a new training stimulus. When a beginner or de-trained individual begins lifting, with eccentric-heavy protocols(thank you Jeff Nippard), the muscle damage response is, no doubt, substantially higher than in conditioned athletes.
Creatine kinase (CK) and lactate dehydrogenase (LDH) levels spike, and the ubiquitin-proteasome system activates, and net muscle protein balance turns negative just for the short term.

HMB directly addresses this. 

In one of these studies², they found that 3g/day HMB during a progressive resistance training program significantly reduced CK compared to placebo, an effect that held regardless of sex or prior training status when later confirmed in a larger cohort by this other study³. Separately, this next study⁴ demonstrated that HMB significantly blunted both CK and LDH responses following a 20km run in trained endurance runners, suggesting the protective effect extends beyond the gym, into cardiovascular sights.

The ISSN’s 2024 updated Position Stand on HMB⁵ affirmed that HMB attenuates exercise-induced skeletal muscle damage across both trained and untrained populations, just one caveat. The evidence in elite resistance-trained athletes is more mixed, an essential nuance. In well-trained individuals already adapted to high training loads, the magnitude of HMB’s protective effect tends to be smaller or negligent, because the catabolic stimulus is already better managed by the adapted body. 

For someone new to training, returning after a while, or beginning a phase with substantially heavier eccentric load than their recent history, HMB’s damage-reducing profile may be a meaningful tool for training consistency across those rough early weeks.

Aging and Sarcopenia

HMB’s evidence base is deepest and the most consistent in this demographic. Sarcopenia (age-related loss of skeletal muscle mass and function) is driven in large part by a chronic upregulation of the same catabolic pathways HMB targets, our body creates a progressively harder environment for us to maintain lean mass.

A 2024 systematic review and meta-analysis⁶, which covered five RCTs in 257 elderly sarcopenic patients, found that exercise combined with HMB supplementation significantly improved gait speed compared to exercise with placebo alone.
A separate 2024 meta-analysis⁷ found statistically significant improvement in handgrip strength in sarcopenic patients supplementing with HMB
A broader 2025 meta-analysis⁸ pooling 21 RCTs across 1,935 adults over 50 found meaningful improvements in both lean mass and grip strength, with effects most visible at 3g/day for durations above 12 weeks.

Importantly, these improvements occur in a population where they keep losing muscle mass without appropriate intervention.
In the context of sarcopenia, HMB is the right tool for the job.

Immobilization and Disuse

HMB’s most underappreciated, most mechanistically clean one is its clinical application. Bed rest, post-surgical recovery, illness, and injury all activate the ubiquitin-proteasome system aggressively. This match between the problem and the mechanism is right there.

One of the pieces of evidence for HMB comes from this randomized, controlled, double-blind trial⁹.
Twenty-four healthy older adults were confined to complete bed rest for ten days. Those supplementing with 3g/day HMB preserved total lean and leg lean mass significantly better than the placebo group, which lost measurable muscle across both departments. The authors concluded that HMB supplementation “preserves muscle mass during 10 days of bed rest” in healthy older adults.
To Be Noted: this was a relatively small trial (n=24) and the researchers acknowledged the need for confirmation in a larger study.
But, the mechanistic logic is supported and the directional finding is consistent with HMB’s known catabolic suppression profile.

The literature adds two further pieces of evidence that speak directly to the same underlying mechanism. Both randomized, double-blind, placebo-controlled trials using the same HMB/arginine/glutamine mixture at 3g HMB daily.
In the first study¹⁰, they tested HMB in 68 HIV-positive patients with documented AIDS-associated muscle wasting, and this second study¹¹ extended the investigation into cancer cachexia in patients with solid tumors who had lost at least 5% of body weight.
We saw the same result: Subjects receiving the HMB-containing stack gained lean mass while the control subjects lost it.
The important caveat: HMB was not administered alone, so its individual contribution cannot be fully separated from arginine and glutamine in the mixture.
Although, what they have demonstrated is that a HMB-containing anti-catabolic stack can meaningfully reduce the amount of lean mass loss under conditions of severe, sustained catabolism.

For anyone who’s facing a forced period of inactivity, be it surgery recovery, injury, or extended illnesses, we see that HMB has an evidence-backed mechanistic rationale that few other supplements can claim in this specific context.